European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.2. Long-term immunosuppression. Therapy conversion.
GUIDELINE: Conversion of immunosuppressive drug therapy is recommended to avoid or reduce drug-specific adverse effects, and is generally safe for long-term graft outcome.
D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*
D007166:Immunosuppressive Agents